Inactief instrument

Koers Islet Sciences Inc OTC Bulletin Board

Aandelen

slotkoers OTC Bulletin Board Andere beurzen
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04-05-15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23-04-15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24-03-15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09-03-15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05-03-15

Sector

	Vaira. 1 jan.	Kapi.
MODERNA, INC.	+40,16%	54,04 mld.
LONZA GROUP AG	+45,32%	41,96 mld.
IQVIA HOLDINGS INC.	-1,46%	41,92 mld.
CELLTRION, INC.	-7,20%	28,35 mld.
ICON PUBLIC LIMITED COMPANY	+12,59%	26,35 mld.
ALNYLAM PHARMACEUTICALS, INC.	-21,10%	19 mld.
BIO-TECHNE CORPORATION	+7,27%	13 mld.
MEDPACE HOLDINGS, INC.	+28,28%	12,28 mld.
UNITED THERAPEUTICS CORPORATION	+26,17%	12,19 mld.